After 5-Year Winning Streak, Xarelto Makers Settle Personal Injury Suits
Executive Summary
Bayer and Johnson & Johnson agree to resolve approximately 25,000 claims in federal and state courts for $775m, almost 13% of Xarelto's 2018 sales.
You may also be interested in...
Purdue's 'Landmark' Settlement With Oklahoma May Be Harbinger Of MDL Resolution
Company is paying nearly $200m for an Oklahoma State University endowment, $12.5m to abate effects of opioid crisis and $60m for litigation costs.
With 5-0 Winning Streak, Bayer And J&J Move To Eliminate Remaining Xarelto Litigation
Firms want Fifth Circuit to review whether federal law preempts failure-to-warn and design-defect claims; ruling in their favor could end 20,000-plus pending US cases.
Strong Xarelto Label Warnings Lead To Another Jury Win For Bayer And Janssen
Philadelphia jurors find that warnings of bleeding risk with Xarelto are adequate, giving companies 5-0 litigation score; sixth trial in June.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: